nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—vagus nerve—esophageal cancer	0.176	0.279	CbGeAlD
Amisulpride—HTR2A—vagus nerve—esophageal cancer	0.11	0.174	CbGeAlD
Amisulpride—Sulpiride—CA2—esophageal cancer	0.0641	1	CrCbGaD
Amisulpride—HTR7—neck—esophageal cancer	0.0387	0.0612	CbGeAlD
Amisulpride—HTR2B—smooth muscle tissue—esophageal cancer	0.0296	0.0468	CbGeAlD
Amisulpride—HTR7—epithelium—esophageal cancer	0.0263	0.0416	CbGeAlD
Amisulpride—HTR7—smooth muscle tissue—esophageal cancer	0.0254	0.0401	CbGeAlD
Amisulpride—HTR2A—neck—esophageal cancer	0.0241	0.0382	CbGeAlD
Amisulpride—HTR2B—digestive system—esophageal cancer	0.0234	0.037	CbGeAlD
Amisulpride—HTR7—trachea—esophageal cancer	0.0233	0.0368	CbGeAlD
Amisulpride—HTR7—digestive system—esophageal cancer	0.02	0.0317	CbGeAlD
Amisulpride—HTR2B—lung—esophageal cancer	0.0195	0.0309	CbGeAlD
Amisulpride—Trismus—Capecitabine—esophageal cancer	0.017	0.056	CcSEcCtD
Amisulpride—HTR7—lung—esophageal cancer	0.0167	0.0265	CbGeAlD
Amisulpride—HTR2A—epithelium—esophageal cancer	0.0164	0.026	CbGeAlD
Amisulpride—HTR2A—smooth muscle tissue—esophageal cancer	0.0158	0.025	CbGeAlD
Amisulpride—DRD2—lung—esophageal cancer	0.0158	0.025	CbGeAlD
Amisulpride—HTR2A—trachea—esophageal cancer	0.0145	0.023	CbGeAlD
Amisulpride—HTR2B—lymph node—esophageal cancer	0.0134	0.0211	CbGeAlD
Amisulpride—HTR2A—digestive system—esophageal cancer	0.0125	0.0198	CbGeAlD
Amisulpride—Sudden death—Capecitabine—esophageal cancer	0.0111	0.0366	CcSEcCtD
Amisulpride—HTR2A—lung—esophageal cancer	0.0104	0.0165	CbGeAlD
Amisulpride—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00934	0.0307	CcSEcCtD
Amisulpride—Sudden death—Methotrexate—esophageal cancer	0.00826	0.0272	CcSEcCtD
Amisulpride—Torsade de pointes—Capecitabine—esophageal cancer	0.0081	0.0267	CcSEcCtD
Amisulpride—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00742	0.0244	CcSEcCtD
Amisulpride—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00695	0.0229	CcSEcCtD
Amisulpride—Pulmonary embolism—Capecitabine—esophageal cancer	0.00568	0.0187	CcSEcCtD
Amisulpride—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00511	0.0168	CcSEcCtD
Amisulpride—Sweating increased—Cisplatin—esophageal cancer	0.00471	0.0155	CcSEcCtD
Amisulpride—Pulmonary embolism—Methotrexate—esophageal cancer	0.00423	0.0139	CcSEcCtD
Amisulpride—Vaginal inflammation—Methotrexate—esophageal cancer	0.00423	0.0139	CcSEcCtD
Amisulpride—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00422	0.0139	CcSEcCtD
Amisulpride—Vaginal infection—Methotrexate—esophageal cancer	0.00399	0.0131	CcSEcCtD
Amisulpride—Bradycardia—Cisplatin—esophageal cancer	0.00394	0.013	CcSEcCtD
Amisulpride—Cardiac arrest—Capecitabine—esophageal cancer	0.00392	0.0129	CcSEcCtD
Amisulpride—Gynaecomastia—Methotrexate—esophageal cancer	0.00378	0.0125	CcSEcCtD
Amisulpride—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00377	0.0124	CcSEcCtD
Amisulpride—Cardiac disorder—Cisplatin—esophageal cancer	0.00359	0.0118	CcSEcCtD
Amisulpride—Immune system disorder—Cisplatin—esophageal cancer	0.00349	0.0115	CcSEcCtD
Amisulpride—Sweating increased—Capecitabine—esophageal cancer	0.00347	0.0114	CcSEcCtD
Amisulpride—Malnutrition—Cisplatin—esophageal cancer	0.00337	0.0111	CcSEcCtD
Amisulpride—Neutropenia—Capecitabine—esophageal cancer	0.00333	0.011	CcSEcCtD
Amisulpride—Weight increased—Capecitabine—esophageal cancer	0.00324	0.0107	CcSEcCtD
Amisulpride—Muscle spasms—Cisplatin—esophageal cancer	0.00324	0.0107	CcSEcCtD
Amisulpride—Weight decreased—Capecitabine—esophageal cancer	0.00322	0.0106	CcSEcCtD
Amisulpride—Hyperglycaemia—Capecitabine—esophageal cancer	0.00321	0.0106	CcSEcCtD
Amisulpride—Depression—Capecitabine—esophageal cancer	0.00317	0.0104	CcSEcCtD
Amisulpride—Tremor—Cisplatin—esophageal cancer	0.00316	0.0104	CcSEcCtD
Amisulpride—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00311	0.0103	CcSEcCtD
Amisulpride—Leukopenia—Cisplatin—esophageal cancer	0.00301	0.00993	CcSEcCtD
Amisulpride—Agranulocytosis—Capecitabine—esophageal cancer	0.00296	0.00977	CcSEcCtD
Amisulpride—Convulsion—Cisplatin—esophageal cancer	0.00292	0.00961	CcSEcCtD
Amisulpride—Bradycardia—Capecitabine—esophageal cancer	0.0029	0.00956	CcSEcCtD
Amisulpride—Anxiety—Cisplatin—esophageal cancer	0.00286	0.00941	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00285	0.00938	CcSEcCtD
Amisulpride—Nervous system disorder—Cisplatin—esophageal cancer	0.0027	0.00888	CcSEcCtD
Amisulpride—Skin disorder—Cisplatin—esophageal cancer	0.00267	0.00879	CcSEcCtD
Amisulpride—Hyperhidrosis—Cisplatin—esophageal cancer	0.00266	0.00875	CcSEcCtD
Amisulpride—Cardiac disorder—Capecitabine—esophageal cancer	0.00265	0.00872	CcSEcCtD
Amisulpride—Angiopathy—Capecitabine—esophageal cancer	0.00259	0.00852	CcSEcCtD
Amisulpride—Immune system disorder—Capecitabine—esophageal cancer	0.00258	0.00849	CcSEcCtD
Amisulpride—Hypotension—Cisplatin—esophageal cancer	0.00257	0.00846	CcSEcCtD
Amisulpride—Mental disorder—Capecitabine—esophageal cancer	0.0025	0.00823	CcSEcCtD
Amisulpride—Malnutrition—Capecitabine—esophageal cancer	0.00248	0.00818	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—esophageal cancer	0.00248	0.00817	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—esophageal cancer	0.00244	0.00805	CcSEcCtD
Amisulpride—Muscle spasms—Capecitabine—esophageal cancer	0.00239	0.00786	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00237	0.00782	CcSEcCtD
Amisulpride—Depression—Methotrexate—esophageal cancer	0.00236	0.00777	CcSEcCtD
Amisulpride—Tremor—Capecitabine—esophageal cancer	0.00233	0.00766	CcSEcCtD
Amisulpride—Leukopenia—Capecitabine—esophageal cancer	0.00222	0.00732	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—esophageal cancer	0.00221	0.00727	CcSEcCtD
Amisulpride—Hypertension—Capecitabine—esophageal cancer	0.00214	0.00706	CcSEcCtD
Amisulpride—Anxiety—Capecitabine—esophageal cancer	0.00211	0.00694	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0021	0.00691	CcSEcCtD
Amisulpride—Dry mouth—Capecitabine—esophageal cancer	0.00207	0.00681	CcSEcCtD
Amisulpride—Hypersensitivity—Cisplatin—esophageal cancer	0.00203	0.00667	CcSEcCtD
Amisulpride—Nervous system disorder—Capecitabine—esophageal cancer	0.00199	0.00655	CcSEcCtD
Amisulpride—Asthenia—Cisplatin—esophageal cancer	0.00197	0.0065	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—esophageal cancer	0.00197	0.00649	CcSEcCtD
Amisulpride—Skin disorder—Capecitabine—esophageal cancer	0.00197	0.00648	CcSEcCtD
Amisulpride—Hyperhidrosis—Capecitabine—esophageal cancer	0.00196	0.00645	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—esophageal cancer	0.00193	0.00634	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—esophageal cancer	0.00192	0.00632	CcSEcCtD
Amisulpride—Hypotension—Capecitabine—esophageal cancer	0.00189	0.00624	CcSEcCtD
Amisulpride—Diarrhoea—Cisplatin—esophageal cancer	0.00188	0.00619	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—esophageal cancer	0.00186	0.00613	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—esophageal cancer	0.00185	0.00609	CcSEcCtD
Amisulpride—Insomnia—Capecitabine—esophageal cancer	0.00183	0.00604	CcSEcCtD
Amisulpride—Dyspepsia—Capecitabine—esophageal cancer	0.00178	0.00588	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00175	0.00576	CcSEcCtD
Amisulpride—Vomiting—Cisplatin—esophageal cancer	0.00175	0.00576	CcSEcCtD
Amisulpride—Fatigue—Capecitabine—esophageal cancer	0.00175	0.00575	CcSEcCtD
Amisulpride—Constipation—Capecitabine—esophageal cancer	0.00173	0.00571	CcSEcCtD
Amisulpride—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00166	0.00546	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—esophageal cancer	0.00165	0.00545	CcSEcCtD
Amisulpride—Nausea—Cisplatin—esophageal cancer	0.00163	0.00538	CcSEcCtD
Amisulpride—Urticaria—Capecitabine—esophageal cancer	0.00161	0.0053	CcSEcCtD
Amisulpride—Abdominal pain—Capecitabine—esophageal cancer	0.0016	0.00528	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—esophageal cancer	0.0016	0.00527	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00156	0.00515	CcSEcCtD
Amisulpride—Hypersensitivity—Capecitabine—esophageal cancer	0.00149	0.00492	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—esophageal cancer	0.00148	0.00487	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—esophageal cancer	0.00147	0.00483	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—esophageal cancer	0.00146	0.0048	CcSEcCtD
Amisulpride—Asthenia—Capecitabine—esophageal cancer	0.00145	0.00479	CcSEcCtD
Amisulpride—Pruritus—Capecitabine—esophageal cancer	0.00143	0.00472	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—esophageal cancer	0.00141	0.00464	CcSEcCtD
Amisulpride—Diarrhoea—Capecitabine—esophageal cancer	0.00139	0.00457	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—esophageal cancer	0.00136	0.00449	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—esophageal cancer	0.00134	0.00442	CcSEcCtD
Amisulpride—Dizziness—Capecitabine—esophageal cancer	0.00134	0.00441	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—esophageal cancer	0.00133	0.00437	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.0013	0.00429	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—esophageal cancer	0.0013	0.00428	CcSEcCtD
Amisulpride—Vomiting—Capecitabine—esophageal cancer	0.00129	0.00424	CcSEcCtD
Amisulpride—Headache—Capecitabine—esophageal cancer	0.00127	0.00418	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00123	0.00406	CcSEcCtD
Amisulpride—Nausea—Capecitabine—esophageal cancer	0.0012	0.00396	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—esophageal cancer	0.0012	0.00395	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—esophageal cancer	0.00119	0.00393	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—esophageal cancer	0.00111	0.00366	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—esophageal cancer	0.00108	0.00356	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—esophageal cancer	0.00107	0.00352	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—esophageal cancer	0.00103	0.0034	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—esophageal cancer	0.000998	0.00329	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—esophageal cancer	0.000959	0.00316	CcSEcCtD
Amisulpride—Headache—Methotrexate—esophageal cancer	0.000945	0.00311	CcSEcCtD
Amisulpride—Nausea—Methotrexate—esophageal cancer	0.000896	0.00295	CcSEcCtD
